Trial site
Catalina Research Institute, LLC
- 18running trials
- 15closed trials
The trials here
What the 33 trials at this site are about, from their registry records.
- Conditions
- Type 2 diabetes13 trials
- Obesity11 trials
- Fatty liver disease (MASLD/MASH)6 trials
- Bipolar disorder3 trials
- Depression3 trials
- Chronic kidney disease2 trials
- Liver cirrhosis2 trials
- Type 1 diabetes2 trials
- Cytomegalovirus infection1 trial
- High blood pressure1 trial
- Schizophrenia1 trial
- Ulcerative colitis1 trial
- Phase
- Phase 318 trials
- Phase 213 trials
- Phase 1/21 trial
- Phase 41 trial
- Status
- Completed14 trials
- Recruiting11 trials
- Active, not recruiting5 trials
- Not yet recruiting2 trials
- Terminated1 trial
- Lead sponsor
- Eli Lilly and Company11 trials
- Boehringer Ingelheim5 trials
- Biomea Fusion Inc.3 trials
- Bristol-Myers Squibb3 trials
- Novo Nordisk A/S3 trials
- and 8 more
Running trials
Not yet recruiting
Not yet recruiting
A Study of Brenipatide in Participants With Major Depressive Disorder
Recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
A Study of Brenipatide in Adult Participants With Schizophrenia
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With TRD
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Bipolar disorder3 recruiting
- Fatty liver disease (MASLD/MASH)3 recruiting
- Type 2 diabetes3 recruiting
- Depression2 recruiting
- Liver cirrhosis2 recruiting
- Obesity2 recruiting
- High blood pressure1 recruiting
- Schizophrenia1 recruiting
Closed trials
Completed
Completed
Completed
Completed
Completed
Completed
Study to Evaluate the Efficacy and Safety of DA-1241 in Subjects With Presumed NASH
Completed
Completed
A Study of Orforglipron in Adult Participants With Obesity or Overweight and Type 2 Diabetes
Completed
Study of BMF-219 in Healthy Adult Subjects and in Adult Subjects With Type 2 Diabetes Mellitus (T2D)
Completed
Completed
Terminated
Completed
A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight
Completed
A Study of Tirzepatide (LY3298176) in Participants With Nonalcoholic Steatohepatitis (NASH)
Completed
Site data: ClinicalTrials.govUpdated 13 Nov 2026